FGF10 induces migration and invasion in pancreatic cancer cells through interaction with FGFR2, resulting in a poor prognosis, thus FGF10/FGFR2 signaling is a promising target for new molecular therapy against pancreatic cancer (Nomura et al., 2008). Here, FGFR2 is linked to familial pancreatic carcinoma.